(NYSE: CHE) Chemed's forecast annual revenue growth rate of 5.67% is forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 4.02%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 15.08%.
Chemed's revenue in 2026 is $2,595,001,000.On average, 5 Wall Street analysts forecast CHE's revenue for 2026 to be $35,811,693,140, with the lowest CHE revenue forecast at $34,400,137,352, and the highest CHE revenue forecast at $37,380,088,460. On average, 5 Wall Street analysts forecast CHE's revenue for 2027 to be $37,942,096,783, with the lowest CHE revenue forecast at $36,569,750,878, and the highest CHE revenue forecast at $39,680,401,596.
In 2028, CHE is forecast to generate $39,798,031,245 in revenue, with the lowest revenue forecast at $38,608,664,794 and the highest revenue forecast at $41,366,426,565.